S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Stock market today: Asian stocks track Wall Street's decline as Middle East tensions escalate
Native American-led nonprofit says it bought 40 acres in the Black Hills of South Dakota
Tax Day reveals a major split in how Joe Biden and Donald Trump would govern
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Stock market today: Asian stocks track Wall Street's decline as Middle East tensions escalate
Native American-led nonprofit says it bought 40 acres in the Black Hills of South Dakota
Tax Day reveals a major split in how Joe Biden and Donald Trump would govern
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Stock market today: Asian stocks track Wall Street's decline as Middle East tensions escalate
Native American-led nonprofit says it bought 40 acres in the Black Hills of South Dakota
Tax Day reveals a major split in how Joe Biden and Donald Trump would govern
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Stock market today: Asian stocks track Wall Street's decline as Middle East tensions escalate
Native American-led nonprofit says it bought 40 acres in the Black Hills of South Dakota
Tax Day reveals a major split in how Joe Biden and Donald Trump would govern

Syndax Pharmaceuticals (SNDX) Earnings Date, Estimates & Call Transcripts

$21.72
-0.60 (-2.69%)
(As of 04/12/2024 08:52 PM ET)

Earnings Summary

Upcoming
Earnings Date
May. 13Estimated
Actual EPS
(Feb. 27)
-$1.00 Missed By -$0.01
Consensus EPS
(Feb. 27)
-$0.99
Skip Charts & View Estimated and Actual Earnings Data

SNDX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

SNDX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Syndax Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242($1.00)($0.91)($0.96)
Q2 20242($1.04)($0.95)($1.00)
Q3 20242($1.03)($0.99)($1.01)
Q4 20242($1.05)($0.78)($0.92)
FY 20248($4.12)($3.63)($3.88)

SNDX Earnings Date and Information

Syndax Pharmaceuticals last issued its quarterly earnings data on February 27th, 2024. The reported ($1.00) earnings per share for the quarter, missing the consensus estimate of ($0.99) by $0.01. Syndax Pharmaceuticals has generated ($2.96) earnings per share over the last year (($2.96) diluted earnings per share). Earnings for Syndax Pharmaceuticals are expected to grow in the coming year, from ($3.70) to ($2.86) per share. Syndax Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 13th, 2024 based off prior year's report dates.

Syndax Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/13/2024
Estimated)
------- 
2/27/2024Q4 2023($0.99)($1.00)($0.01)($1.00)--    
11/2/2023Q3 2023($0.80)($0.73)+$0.07($0.73)--
8/3/2023Q2 2023($0.73)($0.64)+$0.09($0.64)--  
5/8/2023Q1 2023($0.61)($0.59)+$0.02($0.59)--
2/28/2023Q4 2022($0.64)($0.62)+$0.02($0.62)--    
11/3/2022Q3 2022($0.65)($0.58)+$0.07($0.58)--    
8/8/2022Q2 2022($0.65)($0.62)+$0.03($0.62)--
5/9/2022Q1 2022($0.63)($0.63)-($0.63)--    
3/1/2022Q4 2021($0.68)$1.81+$2.49$1.81-$126.58 million    
11/15/2021Q3 2021($0.64)($0.40)+$0.24($0.40)-$12.38 million    
8/9/2021Q2 2021($0.74)($0.44)+$0.30($0.44)$0.50 million$0.38 million    
5/11/2021Q1 2021($0.63)($0.54)+$0.09($0.54)$0.50 million$0.38 million  

Syndax Pharmaceuticals Earnings - Frequently Asked Questions

When is Syndax Pharmaceuticals's earnings date?

Syndax Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 13th, 2024 based off last year's report dates. Learn more on SNDX's earnings history.

Did Syndax Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, Syndax Pharmaceuticals (NASDAQ:SNDX) missed the analysts' consensus estimate of ($0.99) by $0.01 with a reported earnings per share (EPS) of ($1.00). Learn more on analysts' earnings estimate vs. SNDX's actual earnings.

How can I listen to Syndax Pharmaceuticals's earnings conference call?

The conference call for Syndax Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call

How can I read Syndax Pharmaceuticals's conference call transcript?

The conference call transcript for Syndax Pharmaceuticals's latest earnings report can be read online. Read Transcript

How much revenue does Syndax Pharmaceuticals generate each year?

Syndax Pharmaceuticals (NASDAQ:SNDX) has a recorded annual revenue of $139.71 million.

How much profit does Syndax Pharmaceuticals generate each year?

Syndax Pharmaceuticals (NASDAQ:SNDX) has a recorded net income of -$209.36 million. SNDX has generated -$2.96 earnings per share over the last four quarters.

What is Syndax Pharmaceuticals's EPS forecast for next year?

Syndax Pharmaceuticals's earnings are expected to grow from ($3.70) per share to ($2.86) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:SNDX) was last updated on 4/15/2024 by MarketBeat.com Staff

From Our Partners